studyType

URI: https://gptkb.org/prop/studyType
141 triples
GPTKB property
Alternative names (1)
studyDesign
Random triples
Subject Object
gptkb:Women's_Health_Initiative observational study
gptkb:Heart_to_Hub:_A_Randomized,_Open-label,_Multicenter_Study_to_Evaluate_the_Efficacy_and_Safety_of_the_MitraClip_Device_in_Patients_with_Severe_Mitral_Regurgitation open-label
gptkb:JUPITER_trial gptkb:clinical_trial
gptkb:STAR*D_study pragmatic trial
gptkb:NCT00239681 Interventional
gptkb:RE-LY_trial gptkb:clinical_trial
gptkb:Diabetes_Prevention_Program gptkb:clinical_trial
gptkb:PG-NCD interventional
gptkb:PALL_trial interventional
gptkb:CFAS_II longitudinal
gptkb:CLARITY-AD randomized
gptkb:LEADERS_II prospective
gptkb:FELIX_study interventional
gptkb:NCT05149502 Interventional
gptkb:Heart_to_Hub:_A_Randomized,_Open-label,_Multicenter_Study_to_Evaluate_the_Efficacy_and_Safety_of_the_MitraClip_Device_in_Patients_with_Severe_Mitral_Regurgitation randomized
gptkb:NCT00403767 Interventional
gptkb:A_Study_of_Pembrolizumab_(MK-3475)_in_Combination_With_Axitinib_as_First-Line_Treatment_for_Locally_Advanced_or_Metastatic_Renal_Cell_Carcinoma_(MK-3475-426/KEYNOTE-426) Interventional
gptkb:CORIVRON_2 interventional
gptkb:CFAS_Newcastle population-based study
gptkb:S1800A_(immunotherapy_trial) Phase II clinical trial